News
Merck partners with Innervia on bioelectronic therapy development
German pharma company Merck has inked a new deal with Innvervia Bioelectronics to co-develop smart neurostimulators for the treatment of severe chronic diseases.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
German pharma company Merck has inked a new deal with Innvervia Bioelectronics to co-develop smart neurostimulators for the treatment of severe chronic diseases.